Genomictree Inc
228760.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$517.51B
Close$
Share Statistics
| Market cap | $517.51 Billion |
|---|---|
| Enterprise Value | $500.09 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-374.27 |
| Beta | 0.02 |
| Outstanding Shares | 24,308,248 |
Return
| Return on Equity | -7.42% |
|---|---|
| Return on Assets | -7.26% |
| Return on Invested Capital | -11.61% |
Valuation & Multiples
| P/E Ratio | -30.22 |
|---|---|
| PEG | -42.63 |
| Price to Sales | 174.38 |
| Price to Book Ratio | 4.21 |
| Enterprise Value to Revenue | 169.73 |
| Enterprise Value to EBIT | -35.01 |
| Enterprise Value to Net Income | -56 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Genomictree Inc.
76 employees
CEO: Sung-Whan An Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to develop and market advanced detection tools for both oncological conditions and various infectious diseases. Its product line includes EarlyTect C, a screening...